Boston Scientific Recalls All Implantable Defibrillators, Suspends Sales
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is recalling all lines of its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators nationwide because the firm made manufacturing process changes without proper FDA approval